vimarsana.com
Home
Live Updates
Findings Demonstrated - Breaking News
Pages:
Findings Demonstrated News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Artax Biopharma Announces Positive Phase 1 Results for AX-158, Company s First-in-Class Oral Immunomodulator Developed to Treat T Cell-Mediated Diseases
/PRNewswire/ Artax Biopharma, Inc., a clinical-stage biotechnology company focused on transforming the treatment of T Cell-mediated diseases, today.
United kingdom
Joseph lobacki
Clinical development efforts
Prnewswire artax biopharma inc
Findings demonstrated
Investigational agent
Well tolerated
All doses
Strongly supports further clinical development
Being developed
Once daily oral dosing
Address autoimmune diseases
Providing immunomodulation
Officer joseph
Artax biopharma
Health care amp hospitals
vimarsana © 2020. All Rights Reserved.